PriceTargets.com logo

National Vision - EYE Stock Price Target and Predictions

  • Consensus Rating: Moderate Buy
  • Consensus Price Target: $17.57
  • Forecasted Upside: -6.83%
  • Number of Analysts: 8
  • Breakdown:
  • 0 Sell Ratings
  • 4 Hold Ratings
  • 4 Buy Ratings
  • 0 Strong Buy Ratings
$18.86 As of 05/13/2025 05:00 PM ET
▲ +0.1 (0.53%)

This chart shows the closing price for EYE by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New National Vision Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for EYE and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for EYE

Analyst Price Target is $17.57
▼ -6.83% Downside Potential
This price target is based on 8 analysts offering 12 month price targets for National Vision in the last 3 months. The average price target is $17.57, with a high forecast of $21.00 and a low forecast of $13.00. The average price target represents a -6.83% upside from the last price of $18.86.

This chart shows the closing price for EYE for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Moderate Buy

The current consensus among 8 polled investment analysts is to moderate buy stock in National Vision. This rating changed within the last month from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 5 hold ratings
  • 0 sell ratings
Ratings as of
11/21/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 5 hold ratings
  • 0 sell ratings
Ratings as of
2/19/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 5 hold ratings
  • 0 sell ratings
Ratings as of
5/19/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
8/17/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
11/15/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 4 hold ratings
  • 0 sell ratings
Ratings as of
2/13/2025
  • 0 strong buy ratings
  • 1 buy ratings
  • 5 hold ratings
  • 0 sell ratings
Ratings as of
4/14/2025
  • 0 strong buy ratings
  • 4 buy ratings
  • 4 hold ratings
  • 0 sell ratings
Ratings as of
5/14/2025

Latest Recommendations

  • 0 strong buy ratings
  • 4 buy ratings
  • 4 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
5/12/2025BarclaysBoost TargetEqual Weight ➝ Equal Weight$14.00 ➝ $17.00
5/9/2025The Goldman Sachs GroupBoost TargetNeutral ➝ Neutral$13.00 ➝ $17.00
5/9/2025CitigroupUpgradeNeutral ➝ Buy$13.00 ➝ $21.00
5/8/2025UBS GroupBoost TargetBuy ➝ Buy$18.00 ➝ $20.00
5/8/2025Loop CapitalBoost TargetBuy ➝ Buy$18.00 ➝ $20.00
5/8/2025Wells Fargo & CompanyBoost TargetEqual Weight ➝ Equal Weight$13.00 ➝ $15.00
5/7/2025Bank of AmericaUpgradeUnderperform ➝ Buy
3/7/2025CitigroupBoost TargetNeutral ➝ Neutral$12.00 ➝ $13.00
3/3/2025BarclaysBoost TargetEqual Weight ➝ Equal Weight$12.00 ➝ $14.00
2/27/2025Wells Fargo & CompanyBoost TargetEqual Weight ➝ Equal Weight$12.00 ➝ $13.00
1/21/2025Morgan StanleyLower TargetEqual Weight ➝ Equal Weight$14.00 ➝ $13.00
1/6/2025Wells Fargo & CompanyLower TargetEqual Weight ➝ Equal Weight$13.00 ➝ $12.00
8/9/2024The Goldman Sachs GroupLower TargetNeutral ➝ Neutral$20.00 ➝ $13.00
8/8/2024BarclaysLower TargetEqual Weight ➝ Equal Weight$16.00 ➝ $11.00
8/8/2024UBS GroupLower TargetBuy ➝ Buy$20.00 ➝ $18.00
5/10/2024BarclaysLower TargetEqual Weight ➝ Equal Weight$19.00 ➝ $16.00
2/28/2024The Goldman Sachs GroupBoost TargetNeutral ➝ Neutral$18.00 ➝ $20.00
11/13/2023Morgan StanleyLower TargetEqual Weight ➝ Equal Weight$20.00 ➝ $19.00
11/10/2023The Goldman Sachs GroupBoost TargetNeutral ➝ Neutral$16.00 ➝ $18.00
10/17/2023The Goldman Sachs GroupDowngradeBuy ➝ Neutral$25.00 ➝ $16.00
8/11/2023BarclaysBoost TargetEqual Weight ➝ Equal Weight$20.00 ➝ $23.00
7/27/2023CitigroupDowngradeBuy ➝ Neutral$28.00 ➝ $22.00
7/27/2023Wells Fargo & CompanyDowngradeOverweight ➝ Equal Weight$30.00 ➝ $21.00
7/27/2023BarclaysLower TargetEqual Weight$23.00 ➝ $20.00
5/12/2023Loop CapitalBoost Target$23.00 ➝ $28.00
5/4/2023Jefferies Financial GroupLower Target$45.00 ➝ $34.00
5/2/2023BarclaysDowngradeOverweight ➝ Equal Weight
3/31/2023Loop CapitalUpgradeHold ➝ Buy$23.00
3/3/2023CitigroupLower TargetBuy$48.00 ➝ $28.00
3/2/2023Morgan StanleyLower TargetEqual Weight$43.00 ➝ $24.00
3/2/2023The Goldman Sachs GroupLower TargetBuy$41.00 ➝ $28.00
3/2/2023UBS GroupLower Target$50.00 ➝ $31.00
3/2/2023Wells Fargo & CompanyLower TargetOverweight$44.00 ➝ $30.00
3/2/2023BarclaysLower TargetOverweight$43.00 ➝ $25.00
1/17/2023Morgan StanleyDowngradeOverweight ➝ Equal Weight
11/16/2022GuggenheimBoost Target$45.00
11/15/2022CitigroupBoost TargetBuy$41.00 ➝ $48.00
11/14/2022The Goldman Sachs GroupBoost TargetBuy$36.00 ➝ $41.00
11/14/2022BarclaysBoost TargetOverweight$39.00 ➝ $43.00
11/11/2022Morgan StanleyBoost TargetOverweight$40.00 ➝ $43.00
11/7/2022Jefferies Financial GroupReiterated RatingBuy$45.00
8/17/2022BarclaysBoost TargetOverweight$28.00 ➝ $39.00
8/15/2022GuggenheimBoost Target$38.00
6/27/2022The Goldman Sachs GroupUpgradeNeutral ➝ Buy$31.00 ➝ $32.00
6/16/2022Morgan StanleyLower TargetOverweight$65.00 ➝ $40.00
4/1/2022BarclaysBoost Target$43.00 ➝ $52.00
3/1/2022The Goldman Sachs GroupLower TargetNeutral$48.00 ➝ $41.00
3/1/2022Morgan StanleyLower TargetOverweight$70.00 ➝ $65.00
3/1/2022CitigroupLower Target$58.00 ➝ $55.00
1/5/2022Wells Fargo & CompanyLower Target$65.00 ➝ $60.00
11/15/2021The Goldman Sachs GroupDowngradeBuy ➝ Neutral$59.00 ➝ $57.00
11/12/2021Bank of AmericaDowngradeBuy ➝ Underperform$63.00 ➝ $50.00
11/10/2021William BlairReiterated RatingOutperform
10/29/2021CitigroupBoost TargetBuy$63.00 ➝ $70.00
10/15/2021Jefferies Financial GroupBoost TargetPositive ➝ Buy$63.00 ➝ $70.00
10/14/2021Morgan StanleyUpgradeEqual Weight ➝ Overweight$57.00 ➝ $70.00
8/27/2021Morgan StanleyDowngradeOverweight ➝ Equal Weight$58.00 ➝ $57.00
8/13/2021Loop CapitalBoost TargetHold$51.00 ➝ $55.00
8/13/2021BMO Capital MarketsBoost TargetMarket Perform$48.00 ➝ $51.00
3/4/2021CitigroupBoost Target$57.00 ➝ $52.00
3/3/2021Wells Fargo & CompanyBoost TargetOverweight$52.00 ➝ $55.00
1/20/2021Morgan StanleyBoost TargetOverweight$48.00 ➝ $58.00
1/11/2021Loop CapitalDowngradeBuy ➝ Hold
11/18/2020Berenberg BankDowngradeBuy ➝ Hold$42.00
11/6/2020Morgan StanleyBoost TargetOverweight$37.00 ➝ $48.00
11/6/2020BarclaysBoost TargetPositive ➝ Overweight$42.00 ➝ $53.00
10/9/2020Jefferies Financial GroupBoost TargetBuy$39.00 ➝ $46.00
8/17/2020BarclaysBoost TargetOverweight$40.00 ➝ $42.00
8/7/2020Morgan StanleyBoost TargetOverweight$34.00 ➝ $37.00
7/30/2020Jefferies Financial GroupBoost TargetBuy$35.00 ➝ $37.00
6/10/2020CitigroupBoost Target$31.00 ➝ $36.00
6/8/2020Wells Fargo & CompanyReiterated RatingBuy$36.00
(Data available from 5/14/2020 forward)

News Sentiment Rating

1.28 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 11 very positive mentions
  • 8 positive mentions
  • 3 negative mentions
  • 1 very negative mentions
Mentions as of
10/16/2024
  • 5 very positive mentions
  • 12 positive mentions
  • 3 negative mentions
  • 3 very negative mentions
Mentions as of
11/15/2024
  • 6 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/15/2024
  • 8 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/14/2025
  • 4 very positive mentions
  • 13 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/13/2025
  • 12 very positive mentions
  • 18 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/15/2025
  • 13 very positive mentions
  • 3 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
Mentions as of
4/14/2025
  • 25 very positive mentions
  • 15 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/14/2025

Current Sentiment

  • 25 very positive mentions
  • 15 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

National Vision logo
National Vision Holdings, Inc., through its subsidiaries, operates as an optical retailer in the United States. The company operates in two segments, Owned & Host and Legacy. It offers eyeglasses and contact lenses, and optical accessory products; provides eye exams through its America's Best, Eyeglass World, Vista Optical, Fred Meyer, and Vista Optical military, as well as Vision Center branded stores; and offers health maintenance organization and optometric services. National Vision Holdings, Inc. was founded in 1990 and is headquartered in Duluth, Georgia.
Read More

Today's Range

Now: $18.86
Low: $18.40
High: $18.93

50 Day Range

MA: $12.56
Low: $10.88
High: $18.76

52 Week Range

Now: $18.86
Low: $9.56
High: $18.93

Volume

2,854,657 shs

Average Volume

1,761,863 shs

Market Capitalization

$1.49 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.02

Frequently Asked Questions

What sell-side analysts currently cover shares of National Vision?

The following equities research analysts have issued stock ratings on National Vision in the last twelve months: Bank of America Co., Barclays PLC, Citigroup Inc., Loop Capital, Morgan Stanley, The Goldman Sachs Group, Inc., UBS Group AG, and Wells Fargo & Company.
View the latest analyst ratings for EYE.

What is the current price target for National Vision?

0 Wall Street analysts have set twelve-month price targets for National Vision in the last year. Their average twelve-month price target is $17.57, suggesting a possible downside of 6.8%. Citigroup Inc. has the highest price target set, predicting EYE will reach $21.00 in the next twelve months. Morgan Stanley has the lowest price target set, forecasting a price of $13.00 for National Vision in the next year.
View the latest price targets for EYE.

What is the current consensus analyst rating for National Vision?

National Vision currently has 4 hold ratings and 4 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for EYE.

What other companies compete with National Vision?

Other companies that are similar to National Vision include Glaukos, Inari Medical, Inspire Medical Systems, iRhythm Technologies and Bausch + Lomb. Learn More about companies similar to National Vision.

How do I contact National Vision's investor relations team?

National Vision's physical mailing address is 2435 COMMERCE AVENUE BLDG. 2200, DULUTH GA, 30096. The company's listed phone number is (770) 822-3600 and its investor relations email address is [email protected]. The official website for National Vision is www.nationalvision.com. Learn More about contacing National Vision investor relations.